Patent Assignment
Reel/Frame 039566/0620
Assignment of Assignor's Interest
Recorded: 2016-08-29
Pages: 22
Assignors
BAYEVER, ELIEL
Executed: 2016-08-22
BLANCHETTE, SARAH F.
Executed: 2016-08-18
FITZGERALD, JONATHAN BASIL
Executed: 2016-08-17
GADDY, DANIEL F.
Executed: 2016-08-18
HENDRIKS, BART S.
Executed: 2016-08-17
KALRA, ASHISH
Executed: 2016-08-18
LEE, HELEN
Executed: 2016-08-17
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(7)
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/208,209 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/216,736 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/273,244 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/281,473 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/302,341 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/323,245 →
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
Application:
62/343,313 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Assignment of Assignor's Interest
Apr 27, 2016
From: BAYEVER, ELIEL; DHINDSA, NAVREET; FITZGERALD, JONATHAN BASIL
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 038396/0850 →
Release of Security Interest
Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →
Assignment of Assignor's Interest
May 1, 2017
From: MERRIMACK PHARMACEUTICALS, INC.
To: IPSEN BIOPHARM LTD.
Reel/Frame 042377/0696 →
Change of Address of Assignee
May 17, 2017
From: MERRIMACK PHARMACEUTICALS, INC.
To: IPSEN BIOPHARM LTD.
Reel/Frame 042522/0334 →